CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-28 | BROWN MICHAEL S Director | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,172 | 1,535 | ||
| 2024-05-21 | LAROSA JOSEPH J EVP General Counsel and Secret | Sale 10b5-1 | −1,865 | $994.90 | $1.9M | 34,678 |
| 2024-05-17 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −22,687 | $979.22 | $22.2M | 467,020 |
| 2024-05-17 | SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | Sale 10b5-1 | −143 | $980.07 | $140K | 466,877 |
| 2024-05-16 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −907 | $967.40 | $877K | 835,476 |
| 2024-05-16 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −3,213 | $968.44 | $3.1M | 832,263 |
| 2024-05-16 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −9,501 | $969.39 | $9.2M | 822,762 |
| 2024-05-16 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −4,669 | $970.26 | $4.5M | 818,093 |
| 2024-05-16 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −4,922 | $971.56 | $4.8M | 813,171 |
| 2024-05-16 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −790 | $972.22 | $768K | 812,381 |
| 2024-05-16 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −2,653 | $973.80 | $2.6M | 809,728 |
| 2024-05-16 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −7,611 | $974.51 | $7.4M | 802,117 |
| 2024-05-16 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −9,242 | $975.48 | $9.0M | 792,875 |
| 2024-05-16 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −4,886 | $976.52 | $4.8M | 787,989 |
| 2024-05-16 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −1,227 | $977.38 | $1.2M | 786,762 |
| 2024-05-16 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −379 | $978.18 | $371K | 786,383 |
| 2024-05-15 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −111 | $965.69 | $107K | 886,272 |
| 2024-05-15 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −782 | $966.29 | $756K | 885,490 |
| 2024-05-15 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −1,428 | $967.45 | $1.4M | 884,062 |
| 2024-05-15 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −3,387 | $968.43 | $3.3M | 880,675 |
Page 27 of 49 · 971 trades